A detailed history of Tri Ri Asset Management Corp transactions in Incyte Corp stock. As of the latest transaction made, Tri Ri Asset Management Corp holds 49,161 shares of INCY stock, worth $3.4 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
49,161
Holding current value
$3.4 Million
% of portfolio
2.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$57.33 - $68.61 $2.82 Million - $3.37 Million
49,161 New
49,161 $3.23 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Tri Ri Asset Management Corp Portfolio

Follow Tri Ri Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Ri Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tri Ri Asset Management Corp with notifications on news.